Incretin-Based Advances in Obesity and T2D Care

Guest: Javier Morales, MD, FACP, FACE For patients with obesity and type 2 diabetes (T2D), emerging incretin-based therapies that target multiple metabolic pathways are producing meaningful weight-loss outcomes. To learn more about these care strategies, tune in as Dr. Javier Morales shares key updates from the 2026 American Diabetes Association Scientific Sessions. Dr. Morales is an Associate Clinical Professor of Medicine at the Barbara and Donald Zucker School of Medicine at Hofstra University and Northwell Health.

Episode metadata supplied by the publisher feed · Published Jun 3, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

Incretin-Based Advances in Obesity and T2D Care

0:00 3:45

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

This is Type 1: Real-Life Type 1 Diabetes Colleen Mitchell Type 1 Diabetes is challenging, frustrating, and life-changing. Each Tuesday, join Colleen Mitchell and Jessie Tuggey, life-long diabetics, as they talk about real life with Type 1, discussing the impact it makes on their lives without defining them. If you have type 1, know someone with type 1, or just want to learn more about this incurable condition, this podcast is for you.

Frequently Asked Questions

How long is this episode of Diabetes Discourse?

This episode is 3 minutes long.

When was this Diabetes Discourse episode published?

This episode was published on June 3, 2026.

Can I download this Diabetes Discourse episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!